Stay updated with breaking news from Trial Assessing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...
Date: July 13, 2023 Public Announcement Incannex Receives HREC Approval for Phase...
Reliance on automated standing orders for prescribing primary prophylaxis colony-stimulating factor did not significantly impact its use.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Share this article Share this article NEW YORK, March 8, 2021 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that four of its funded researchers will be making presentations at the 15 th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™ 2021), which will be held virtually from Barcelona, Spain March 9-14, 2021. "The ADDF seeks out and maintains a diverse portfolio of novel drug and biomarker targets that reflect the many biological pathways implicated in Alzheimer's disease," said Dr. Howard Fillit, Founding Executive Director and Ch...